Browsed by
Category: Success Stories

BioFactura is on Course to Become a Global Leader in Biosimilar Development

BioFactura is on Course to Become a Global Leader in Biosimilar Development

Since the approval of the first biosimilar drug in the United States six years ago, the market has rapidly expanded and is expected to grow to approximately $23 billion in the U.S. by 2027. And Maryland’s BioFactura anticipates it will be one of the companies at the forefront of this revolution of new medications. ...  Read more

FITCI’s Nanobiofab shapes medical training with AI-powered platform

FITCI’s Nanobiofab shapes medical training with AI-powered platform

Tao Treasures LLC DBA Nanobiofab, a minority woman-owned nanotech startup in the Frederick Innovative Technology Center, Inc. (FITCI), is helping medical mannequins tell doctors where it hurts. The company, which creates revolutionary million-scale nanomaterial used in applications ranging from routine health monitoring to cancer detection, is working with West Virginia University (WVU) to improve clinical simulators. The million-dollar effort, initiated through the Defense Health Agency Small Business Innovation Research (SBIR) program, starts in September at Nanobiofab (Frederick, MD) and the David and Jo Ann Shaw Center for Simulation Training and Education for Patient Safety (STEPS) at WVU in Morgantown, WV. ...  Read more

Zalgen Awarded CEPI Contract to Provide Test Kits for Largest Ever Lassa Fever Study in West Africa

Zalgen Awarded CEPI Contract to Provide Test Kits for Largest Ever Lassa Fever Study in West Africa

Three-year contract leading to advance clinical trials for Lassa Fever vaccines reaffirms Zalgen’s focus on preparedness and its dedication to developing solutions for emerging viral threats

 Oslo, Norway & Germantown, Maryland, August 25, 2021 – Zalgen Labs LLC (Zalgen), a biotechnology and diagnostics company focused on preparedness for high impact, neglected infectious diseases including Lassa Fever (LF), today announced its contract with the Coalition for Epidemic Preparedness Innovations (CEPI) to further advance the development of vaccines against Lassa Fever (LF) in West Africa, a region where the disease is endemic. ...  Read more

For The 5th Time, Verity Commercial Appears on The Inc. 5000 List of America’s Fastest-Growing Private Companies

For The 5th Time, Verity Commercial Appears on The Inc. 5000 List of America’s Fastest-Growing Private Companies

For the 5th time, Verity Commercial ranked on the Inc. 5000 list, the most prestigious ranking of the nation’s fastest-growing private companies. Verity’s multidisciplinary business platform and a strong focus on the wellness of its people and clients were key to maintaining stability and growth. ...  Read more

FZata Announces First-in-Class “Live Biologics In A Pill” Platform Entering Manufacturing Phase

FZata Announces First-in-Class “Live Biologics In A Pill” Platform Entering Manufacturing Phase

FZata, Inc. is developing a ground-breaking “Live Biologics In A Pill” platform for oral delivery of live biologics. Live Biologics In A Pill will open up a new route of oral administration for innovative live biologic therapeutics. FZata is pleased to announce that our lead drug, FZ002, has advanced to manufacturing stage and IND-enabling studies. ...  Read more

FITCI Member, Tellor, earns listing on Coinbase as TRB

FITCI Member, Tellor, earns listing on Coinbase as TRB

Frederick-based Tellor started at FITCI in March 2019, committing to its Strategic Growth and Advisory program. Now, investors can buy and sell the startup’s own token (TRB) on Coinbase, the biggest crypto exchange available to US traders. The listing puts Tellor in an elite tier of crypto projects that meet Coinbase’s exacting standards. ...  Read more

Veralox Therapeutics Announces Closing Of $16.6 Million Series A Financing And Announces New Board Members

Veralox Therapeutics Announces Closing Of $16.6 Million Series A Financing And Announces New Board Members

FREDERICK, Md.June 16, 2021 /PRNewswire/ — Veralox Therapeutics, a biotechnology company developing first-in-class small molecule therapeutics that treat the underlying pathologies of diseases with significant unmet medical needs, today announced the closing of a $16.6 million Series A financing.  The round was led by Hatteras Venture Partners with participation from Genesys Capital, Point Field Partners and Alexandria Venture Investments as well as support from previous Veralox investors including Sanofi Ventures, JDRF T1D Fund, Maryland Momentum Fund, VTC Innovation Fund and TEDCO.  The Company also announced that Ben Scruggs, PhD, principal at Hatteras Venture Partners, and Jamie Stiff, MBA, managing director at Genesys Capital, will join the Veralox Therapeutics board of directors. ...  Read more

Liquid Biopsy Predicts Esophageal Cancer Patient Response to Treatment

Liquid Biopsy Predicts Esophageal Cancer Patient Response to Treatment

December 10, 2020 03:58 PM Eastern Standard Time

ROCKVILLE, Md.–(BUSINESS WIRE)–Creatv MicroTech, a privately-held biotechnology company has pioneered a blood test to predict treatment response in patients with newly diagnosed Stage I-III esophageal cancer (EC) treated with chemoradiation therapy (CRT). The results were published in the Journal of Translational Medicine. ...  Read more

Unleashed Technologies Again Named Top Ranked B2B Firm in Maryland

Unleashed Technologies Again Named Top Ranked B2B Firm in Maryland

Unleashed Technologies is once again the leading B2B firm in Maryland.
As the top firm in the state, the digital and web services company outranked a wide variety of B2B firms, including custom software development, branding, design, and more. Criteria for this award include brand reputation, client reviews, and industry expertise.
Clutch is the leading ratings and reviews platform. Each month, over half a million buyers and sellers use Clutch, and the user base keeps growing. ...  Read more